Santoro M - Search Results

1

Promising rodent models in Parkinson's disease.

Imbriani P, Sciamanna G, Santoro M, Schirinzi T, Pisani A. Imbriani P, et al. Among authors: santoro m. Parkinsonism Relat Disord. 2018 Jan;46 Suppl 1:S10-S14. doi: 10.1016/j.parkreldis.2017.07.027. Epub 2017 Jul 27. Parkinsonism Relat Disord. 2018. PMID: 28760592 Review.

2

Enhanced mu opioid receptor-dependent opioidergic modulation of striatal cholinergic transmission in DYT1 dystonia.

Ponterio G, Tassone A, Sciamanna G, Vanni V, Meringolo M, Santoro M, Mercuri NB, Bonsi P, Pisani A. Ponterio G, et al. Among authors: santoro m. Mov Disord. 2018 Feb;33(2):310-320. doi: 10.1002/mds.27212. Epub 2017 Nov 18. Mov Disord. 2018. PMID: 29150865

3

Abnormal striatal plasticity in a DYT11/SGCE myoclonus dystonia mouse model is reversed by adenosine A2A receptor inhibition.

Maltese M, Martella G, Imbriani P, Schuermans J, Billion K, Sciamanna G, Farook F, Ponterio G, Tassone A, Santoro M, Bonsi P, Pisani A, Goodchild RE. Maltese M, et al. Among authors: santoro m. Neurobiol Dis. 2017 Dec;108:128-139. doi: 10.1016/j.nbd.2017.08.007. Epub 2017 Aug 18. Neurobiol Dis. 2017. PMID: 28823931

4

Evaluation of AZD1446 as a Therapeutic in DYT1 Dystonia.

Zimmerman CN, Eskow Jaunarajs KL, Meringolo M, Rizzo FR, Santoro M, Standaert DG, Pisani A. Zimmerman CN, et al. Among authors: santoro m. Front Syst Neurosci. 2017 Jun 13;11:43. doi: 10.3389/fnsys.2017.00043. eCollection 2017. Front Syst Neurosci. 2017. PMID: 28659770 Free PMC article.

5

DJ-1 modulates mitochondrial response to oxidative stress: clues from a novel diagnosis of PARK7.

Di Nottia M, Masciullo M, Verrigni D, Petrillo S, Modoni A, Rizzo V, Di Giuda D, Rizza T, Niceta M, Torraco A, Bianchi M, Santoro M, Bentivoglio AR, Bertini E, Piemonte F, Carrozzo R, Silvestri G. Di Nottia M, et al. Among authors: santoro m. Clin Genet. 2017 Jul;92(1):18-25. doi: 10.1111/cge.12841. Epub 2016 Oct 6. Clin Genet. 2017. PMID: 27460976

6

Prevalence of spinocerebellar ataxia type 2 mutation among Italian Parkinsonian patients.

Modoni A, Contarino MF, Bentivoglio AR, Tabolacci E, Santoro M, Calcagni ML, Tonali PA, Neri G, Silvestri G. Modoni A, et al. Among authors: santoro m. Mov Disord. 2007 Feb 15;22(3):324-7. doi: 10.1002/mds.21228. Mov Disord. 2007. PMID: 17149720

7

Myotonic dystrophy type 1: role of CCG, CTC and CGG interruptions within DMPK alleles in the pathogenesis and molecular diagnosis.

Santoro M, Masciullo M, Silvestri G, Novelli G, Botta A. Santoro M, et al. Clin Genet. 2017 Oct;92(4):355-364. doi: 10.1111/cge.12954. Epub 2017 Feb 22. Clin Genet. 2017. PMID: 27991661 Review.

8

Molecular, clinical, and muscle studies in myotonic dystrophy type 1 (DM1) associated with novel variant CCG expansions.

Santoro M, Masciullo M, Pietrobono R, Conte G, Modoni A, Bianchi ML, Rizzo V, Pomponi MG, Tasca G, Neri G, Silvestri G. Santoro M, et al. J Neurol. 2013 May;260(5):1245-57. doi: 10.1007/s00415-012-6779-9. Epub 2012 Dec 23. J Neurol. 2013. PMID: 23263591

9

Evaluation of levodopa and carbidopa antioxidant activity in normal human lymphocytes in vitro: implication for oxidative stress in Parkinson's disease.

Colamartino M, Santoro M, Duranti G, Sabatini S, Ceci R, Testa A, Padua L, Cozzi R. Colamartino M, et al. Among authors: santoro m. Neurotox Res. 2015 Feb;27(2):106-17. doi: 10.1007/s12640-014-9495-7. Epub 2014 Oct 30. Neurotox Res. 2015. PMID: 25355370

10

What do we know about the role of lncRNAs in multiple sclerosis?

Nociti V, Santoro M. Nociti V, et al. Among authors: santoro m. Neural Regen Res. 2021 Sep;16(9):1715-1722. doi: 10.4103/1673-5374.306061. Neural Regen Res. 2021. PMID: 33510060 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,693 results

Search Page